A clinical study for evaluating the effects of the combined administration of L-citrulline and L-arginine on blood arginine and NOx levels
- Conditions
- one
- Registration Number
- JPRN-UMIN000016647
- Lead Sponsor
- Soiken Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 40
Not provided
1) Subjects who regularly take any drugs for cardiovascular or circulatory organs system 2) Subjects who have a history of heart diseases 3) Subjects who have severe liver, kidney, heart, respiratory, endocrine or metabolic diseases 4) Subjects who have a smoking habit 5) Subjects with a heavy alcohol consumption (>60 g/day) 6) Subjects who have an intake of Citrulline or Arginine 7) Subjects who take any drugs for improving circulating 8) Subjects who have the possibility of developing allergic symptoms by the test food 9) Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months prior to the start of the present study 10)Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 11) Subject deemed unsuitable by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood arginine and NOx levels
- Secondary Outcome Measures
Name Time Method Blood cGMP, 8-isoprostane, MDA-LDL, and triglyceride levels